Literature DB >> 32160234

Impact of blood glucose abnormalities on outcomes and disease severity in patients with severe sepsis: An analysis from a multicenter, prospective survey of severe sepsis.

Shigeki Kushimoto1, Toshikazu Abe2,3, Hiroshi Ogura4, Atsushi Shiraishi5, Daizoh Saitoh6, Seitaro Fujishima7, Toshihiko Mayumi8, Toru Hifumi9, Yasukazu Shiino10, Taka-Aki Nakada11, Takehiko Tarui12, Yasuhiro Otomo13, Kohji Okamoto14, Yutaka Umemura4, Joji Kotani15, Yuichiro Sakamoto16, Junichi Sasaki17, Shin-Ichiro Shiraishi18, Kiyotsugu Takuma19, Ryosuke Tsuruta20, Akiyoshi Hagiwara21, Kazuma Yamakawa22, Tomohiko Masuno23, Naoshi Takeyama24, Norio Yamashita25, Hiroto Ikeda26, Masashi Ueyama27, Satoshi Fujimi22, Satoshi Gando28,29.   

Abstract

BACKGROUND: Dysglycemia is frequently observed in patients with sepsis. However, the relationship between dysglycemia and outcome is inconsistent. We evaluate the clinical characteristics, glycemic abnormalities, and the relationship between the initial glucose level and mortality in patients with sepsis.
METHODS: This is a retrospective sub-analysis of a multicenter, prospective cohort study. Adult patients with severe sepsis (Sepsis-2) were divided into groups based on blood glucose categories (<70 (hypoglycemia), 70-139, 140-179, and ≥180 mg/dL), according to the admission values. In-hospital mortality and the relationship between pre-existing diabetes and septic shock were evaluated.
RESULTS: Of 1158 patients, 69, 543, 233, and 313 patients were categorized as glucose levels <70, 70-139, 140-179, ≥180 mg/dL, respectively. Both the Acute Physiological and Chronic Health Evaluation II and Sequential Organ Failure Assessment (SOFA) scores on the day of enrollment were higher in the hypoglycemic patients than in those with 70-179 mg/dL. The hepatic SOFA scores were also higher in hypoglycemic patients. In-hospital mortality rates were higher in hypoglycemic patients than in those with 70-139 mg/dL (26/68, 38.2% vs 43/221, 19.5%). A significant relationship between mortality and hypoglycemia was demonstrated only in patients without known diabetes. Mortality in patients with both hypoglycemia and septic shock was 2.5-times higher than that in patients without hypoglycemia and septic shock.
CONCLUSIONS: Hypoglycemia may be related to increased severity and high mortality in patients with severe sepsis. These relationships were evident only in patients without known diabetes. Patients with both hypoglycemia and septic shock had an associated increased mortality rate.

Entities:  

Year:  2020        PMID: 32160234      PMCID: PMC7065801          DOI: 10.1371/journal.pone.0229919

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


  34 in total

1.  Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies.

Authors:  Erik von Elm; Douglas G Altman; Matthias Egger; Stuart J Pocock; Peter C Gøtzsche; Jan P Vandenbroucke
Journal:  BMJ       Date:  2007-10-20

Review 2.  Clinical review: Intensive insulin therapy in critically ill patients: NICE-SUGAR or Leuven blood glucose target?

Authors:  Greet Van den Berghe; Miet Schetz; Dirk Vlasselaers; Greet Hermans; Alexander Wilmer; Roger Bouillon; Dieter Mesotten
Journal:  J Clin Endocrinol Metab       Date:  2009-06-16       Impact factor: 5.958

3.  The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3).

Authors:  Mervyn Singer; Clifford S Deutschman; Christopher Warren Seymour; Manu Shankar-Hari; Djillali Annane; Michael Bauer; Rinaldo Bellomo; Gordon R Bernard; Jean-Daniel Chiche; Craig M Coopersmith; Richard S Hotchkiss; Mitchell M Levy; John C Marshall; Greg S Martin; Steven M Opal; Gordon D Rubenfeld; Tom van der Poll; Jean-Louis Vincent; Derek C Angus
Journal:  JAMA       Date:  2016-02-23       Impact factor: 56.272

Review 4.  2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference.

Authors:  Mitchell M Levy; Mitchell P Fink; John C Marshall; Edward Abraham; Derek Angus; Deborah Cook; Jonathan Cohen; Steven M Opal; Jean-Louis Vincent; Graham Ramsay
Journal:  Crit Care Med       Date:  2003-04       Impact factor: 7.598

5.  Alterations in tissue glucose uptake during the hyperglycemic and hypoglycemic phases of sepsis.

Authors:  S R Maitra; M M Wojnar; C H Lang
Journal:  Shock       Date:  2000-05       Impact factor: 3.454

6.  A new method of classifying prognostic comorbidity in longitudinal studies: development and validation.

Authors:  M E Charlson; P Pompei; K L Ales; C R MacKenzie
Journal:  J Chronic Dis       Date:  1987

7.  The relation between hyperglycemia and outcomes in 2,471 patients admitted to the hospital with community-acquired pneumonia.

Authors:  Finlay A McAlister; Sumit R Majumdar; Sandra Blitz; Brian H Rowe; Jacques Romney; Thomas J Marrie
Journal:  Diabetes Care       Date:  2005-04       Impact factor: 19.112

8.  Glucose normalization and outcomes in patients with acute myocardial infarction.

Authors:  Mikhail Kosiborod; Silvio E Inzucchi; Harlan M Krumholz; Frederick A Masoudi; Abhinav Goyal; Lan Xiao; Philip G Jones; Suzanne Fiske; John A Spertus
Journal:  Arch Intern Med       Date:  2009-03-09

9.  Evaluation and management of adult hypoglycemic disorders: an Endocrine Society Clinical Practice Guideline.

Authors:  Philip E Cryer; Lloyd Axelrod; Ashley B Grossman; Simon R Heller; Victor M Montori; Elizabeth R Seaquist; F John Service
Journal:  J Clin Endocrinol Metab       Date:  2008-12-16       Impact factor: 5.958

10.  Hypoglycemia. A common complication of septicemia in cirrhosis.

Authors:  O Nouel; J Bernuau; B Rueff; J P Benhamou
Journal:  Arch Intern Med       Date:  1981-10
View more
  6 in total

1.  Endothelial Glycocalyx Disorders May Be Associated With Extended Inflammation During Endotoxemia in a Diabetic Mouse Model.

Authors:  So Sampei; Hideshi Okada; Hiroyuki Tomita; Chihiro Takada; Kodai Suzuki; Takamasa Kinoshita; Ryo Kobayashi; Hirotsugu Fukuda; Yuki Kawasaki; Ayane Nishio; Hirohisa Yano; Isamu Muraki; Yohei Fukuda; Keiko Suzuki; Nagisa Miyazaki; Takatomo Watanabe; Tomoaki Doi; Takahiro Yoshida; Akio Suzuki; Shozo Yoshida; Shigeki Kushimoto; Shinji Ogura
Journal:  Front Cell Dev Biol       Date:  2021-04-01

Review 2.  Impact of diabetes mellitus on outcomes of patients with sepsis: an updated systematic review and meta-analysis.

Authors:  Li Jiang; Mengdi Cheng
Journal:  Diabetol Metab Syndr       Date:  2022-03-05       Impact factor: 3.320

3.  Clinical Trials of COVID-19 Therapies Should Account for Diabetes and Hyperglycemia.

Authors:  David C Klonoff; Jordan Messler; Timothy Valk; Ram Jagannathan; Francisco J Pasquel; Guillermo E Umpierrez
Journal:  J Diabetes Sci Technol       Date:  2021-06-23

Review 4.  Clotting Dysfunction in Sepsis: A Role for ROS and Potential for Therapeutic Intervention.

Authors:  Maria Elisa Lopes-Pires; Jéssica Oliveira Frade-Guanaes; Gregory J Quinlan
Journal:  Antioxidants (Basel)       Date:  2021-12-30

5.  Sepsis-associated hypoglycemia on admission is associated with increased mortality in intensive care unit patients.

Authors:  Yumi Mitsuyama; Kentaro Shimizu; Sho Komukai; Atsushi Hirayama; Ryosuke Takegawa; Takeshi Ebihara; Tetsuhisa Kitamura; Hiroshi Ogura; Takeshi Shimazu
Journal:  Acute Med Surg       Date:  2022-01-24

6.  High Albumin Level Is Associated With Regression of Glucose Metabolism Disorders Upon Resolution of Acute Liver Inflammation in Hepatitis B-Related Cirrhosis.

Authors:  Caiyun Tian; Yanping Zhu; Yujuan Liu; Han Hu; Qijiao Cheng; Fangwan Yang; Lingqi Pei; Yihong Zhou; Ying Li; Shide Lin
Journal:  Front Cell Infect Microbiol       Date:  2022-02-22       Impact factor: 5.293

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.